Precipio, Inc. Common Stock
$26.46
Market Cap
$47.37M
Shares Outstanding
1.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 18, 2000
Round Lot
100
Locale
US
Day Open
$26.38
Day High
$26.48
Day Low
$25.74
Volume
192.3K
VWAP
$26.14
Prev Close
$26.44
Transactions
--
Acc. Volume
--
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Precipio, Inc. Common Stock (PRPO) closed the 2026-09-18 session at $26.46, up 0.08% versus the previous close (+0.02). The stock opened at $26.38 and traded between $25.74 and $26.48 during that session. Session trading volume was 192K shares. The volume-weighted average price (VWAP) is $26.14.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Precipio, Inc. Common Stock has a market capitalization of $47.4 million. The company operates in the LABORATORY ANALYTICAL INSTRUMENTS industry classification. PRPO is listed on the XNAS exchange. The company employs approximately 71 people. Precipio, Inc. Common Stock is headquartered in NEW HAVEN, CT. The recorded listing date is 2000-07-18.
On this page you can find market PRPO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the LABORATORY ANALYTICAL INSTRUMENTS sector.